In the context of oncological treatment, Hormone Therapy (HT) stands out as a recommended therapeutic approach for women with malignant breast neoplasms that test positive for estrogen receptors (ER) or progesterone receptors (PR). Here, ESR1 is linked to breast neoplasm.